Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
shareholder lawsuits
Biotech
CytoDyn ousts CEO Pourhassan after a wild year
CytoDyn President CEO Nader Pourhassan, Ph.D., is out, and CFO Antonio Migliarese is in, the embattled biotech said Tuesday.
Annalee Armstrong
Jan 26, 2022 10:30am
CytoDyn's shareholders have a plan to get leronlimab approved
Sep 24, 2021 11:37am
Sesen Bio shares crater after report of trial misconduct
Aug 19, 2021 10:05am
CytoDyn catches SEC, DOJ scrutiny over COVID-19 drug
Aug 3, 2021 10:50am
CytoDyn accused by FDA of cherry-picking COVID-19 data
May 17, 2021 4:30pm
Settlement set to sling Soon-Shiong out of biotech investment
Apr 1, 2019 9:30am
